Literature DB >> 2682587

Treatment of multiple subcutaneous Nocardia asteroides abscesses with ciprofloxacin and doxycycline.

P M Bath1, K W Pettingale, J Wade.   

Abstract

We report on the successful use of oral ciprofloxacin and doxycycline in the treatment of multiple subcutaneous nocardial abscesses in an immunocompromised patient with active non-Hodgkin's lymphoma. This relatively inexpensive regimen allowed the patient to return home and was not associated with any significant side effects. The patient has shown no sign of relapse of her nocardial infection over an 8-month period on the above regimen.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2682587      PMCID: PMC2429231          DOI: 10.1136/pgmj.65.761.190

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN: 0032-5473            Impact factor:   2.401


  11 in total

1.  Nocardiosis. A review of 25 cases occurring during 24 months.

Authors:  A R Frazier; E C Rosenow; G D Roberts
Journal:  Mayo Clin Proc       Date:  1975-11       Impact factor: 7.616

2.  Actinomycosis and nocardiosis. A review of basic differences in therapy.

Authors:  J W PEABODY; J H SEABURY
Journal:  Am J Med       Date:  1960-01       Impact factor: 4.965

3.  [Ciprofloxacin and imipenem in nocardiosis].

Authors:  P M Shah; G Just; S Staszewski; E B Helm; R Brodt; W Stille
Journal:  Dtsch Med Wochenschr       Date:  1987-07-03       Impact factor: 0.628

4.  Intravenous ciprofloxacin in the treatment of infection in immunocompromised patients.

Authors:  M E Wood; A C Newland
Journal:  J Antimicrob Chemother       Date:  1986-11       Impact factor: 5.790

5.  Factors affecting survival in nocardiosis.

Authors:  C A Presant; P H Wiernik; A A Serpick
Journal:  Am Rev Respir Dis       Date:  1973-12

6.  Tissue penetration and metabolism of ciprofloxacin.

Authors:  R Wise; I A Donovan
Journal:  Am J Med       Date:  1987-04-27       Impact factor: 4.965

7.  In vitro susceptibilities of Nocardia species to newer antimicrobial agents.

Authors:  P Berkey; D Moore; K Rolston
Journal:  Antimicrob Agents Chemother       Date:  1988-07       Impact factor: 5.191

8.  In vitro susceptibility of Nocardia asteroides to 25 antimicrobial agents.

Authors:  D H Dewsnup; D N Wright
Journal:  Antimicrob Agents Chemother       Date:  1984-02       Impact factor: 5.191

9.  Successful treatment of systemic nocardiosis with co-trimoxazole.

Authors:  S Bayley; P S Robinson; S J Eykyn
Journal:  J Infect       Date:  1981-09       Impact factor: 6.072

10.  Comparative in vitro studies with 4-quinolone antimicrobials.

Authors:  D Felmingham; M D O'Hare; M J Robbins; R A Wall; A H Williams; A W Cremer; G L Ridgway; R N Grüneberg
Journal:  Drugs Exp Clin Res       Date:  1985
View more
  4 in total

1.  In vitro activity of ACH-702, a new isothiazoloquinolone, against Nocardia brasiliensis compared with econazole and the carbapenems imipenem and meropenem alone or in combination with clavulanic acid.

Authors:  Lucio Vera-Cabrera; Mayra Paola Campos-Rivera; Wendy G Escalante-Fuentes; Michael J Pucci; Jorge Ocampo-Candiani; Oliverio Welsh
Journal:  Antimicrob Agents Chemother       Date:  2010-03-22       Impact factor: 5.191

2.  Efficacy of ciprofloxacin and moxifloxacin against Nocardia brasiliensis in vitro and in an experimental model of actinomycetoma in BALB/c mice.

Authors:  Brenda Edith Chacon-Moreno; Oliverio Welsh; Norma Cavazos-Rocha; Maria de la Luz Salazar-Cavazos; Hector Gerardo Garza-Lozano; Salvador Said-Fernandez; Jorge Ocampo-Candiani; Lucio Vera-Cabrera
Journal:  Antimicrob Agents Chemother       Date:  2008-10-13       Impact factor: 5.191

Review 3.  The medically important aerobic actinomycetes: epidemiology and microbiology.

Authors:  M M McNeil; J M Brown
Journal:  Clin Microbiol Rev       Date:  1994-07       Impact factor: 26.132

4.  Actinomycetoma with systemic features: A warning sign for immunosuppression?

Authors:  Rita Fernanda Cortez de Almeida; Roberta Espírito Santo Correia; Andréa Gina Varón; Janice Mery Chicarino de Oliveira Coelho; Ana Paola de Oliveira; Maria Cristina Silva Lourenço; Erica Aparecida Dos Santos Ribeiro da Silva; Emilyn Costa Conceição; Cristiane da Cruz Lamas; Dayvison Francis Saraiva Freitas
Journal:  PLoS Negl Trop Dis       Date:  2020-12-03
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.